Medicine & Life Sciences
ecteinascidin 729
100%
Biological Products
40%
Pharmacology
27%
Biological Assay
17%
Intravenous Administration
15%
Inhibitory Concentration 50
14%
High Pressure Liquid Chromatography
13%
Leukemia P388
12%
Experimental Melanomas
10%
Reverse-Phase Chromatography
10%
DNA Adducts
10%
Guanine
9%
National Cancer Institute (U.S.)
9%
Growth
8%
Buffers
7%
Biological Availability
7%
Half-Life
7%
Pharmacokinetics
6%
Urine
5%
Anti-Bacterial Agents
5%
Injections
4%
DNA
4%
Chemical Compounds
Antiproliferative
40%
Antitumor
37%
Intraperitoneal
31%
High-Pressure Liquid Chromatography
12%
Elimination Half-Life
11%
Peak Plasma Concentration
11%
50 Percent Growth Inhibition
11%
Plasma
10%
Neutral Condition
9%
Clearance
8%
Bioavailability
7%
Guanine
7%
Alkaline Condition
7%
Antineoplastic Agent
7%
Pharmacokinetics
6%
Organic Solvent
6%
Adduct
5%
Antimicrobial Agent
5%
Buffer Solution
5%